Comparing the amount of patient controlled analgesia (PCA) requirement after receiving posterior lumbar interbody fixation surgery with total intravenous anesthesia using propofol with remifentanil or dexmedetomidine

Comparing amount of PCA requirement after total intravenous anesthesia using propofol with remifentanil or dexmedetomidine in patients receiving PLIF

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001041

Enrollment

Registered

2014-04-07

Start date

2013-09-02

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Dexmedetomidine (200mcg) and remifentanil 2mg are each mixed in normal saline in total 50 ml. Before anesthesia induction, dexmedetomine is infused in the rate of 1 mcg/kg/hr in dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients receicing posterior lumbar internal fixation who did not have underlying cardiovascular diseases except diabetes and hypertension (Amerian Society of Anesthesiologists score I-II) and signed for the study permission

Exclusion criteria

Exclusion criteria: patinets who refused to sign for the pesmission patients who have bradycardia under 50 bpm and arrythmia before operation patients who have coronary artery disease or ischemic heart disease patients who are allergic to study drug

Design outcomes

Primary

Measure	Time frame
The amount of PCA used	—

Secondary

Measure	Time frame
pain intensity (VAS, visual analogue scale)	—

Countries

Korea, Republic of

Contacts

Public ContactJin Joo

The Catholic University of Korea, Seoul St. Mary's Hospital

Outcome results